We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warning to Hospira Infusion Plant May Hint at Broader Problems
FDA Warning to Hospira Infusion Plant May Hint at Broader Problems
September 7, 2012
An FDA warning letter issued to Hospira’s infusion pump plant in Costa Rica may be emblematic of broader companywide manufacturing issues, analysts say.